PIZZIGALLO, Eligio
 Distribuzione geografica
Continente #
NA - Nord America 4.090
EU - Europa 4.073
AS - Asia 2.654
SA - Sud America 135
AF - Africa 15
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 2
Totale 10.979
Nazione #
US - Stati Uniti d'America 4.064
CN - Cina 954
UA - Ucraina 942
SG - Singapore 895
IE - Irlanda 687
TR - Turchia 604
GB - Regno Unito 603
FR - Francia 417
SE - Svezia 408
DE - Germania 315
IT - Italia 310
FI - Finlandia 184
IN - India 150
RU - Federazione Russa 133
BR - Brasile 122
CA - Canada 20
CZ - Repubblica Ceca 19
BE - Belgio 11
EU - Europa 10
PL - Polonia 10
AT - Austria 9
HK - Hong Kong 9
IL - Israele 8
VN - Vietnam 7
GR - Grecia 6
MX - Messico 6
IR - Iran 5
ZA - Sudafrica 5
NL - Olanda 4
BD - Bangladesh 3
CH - Svizzera 3
CO - Colombia 3
ES - Italia 3
IQ - Iraq 3
MA - Marocco 3
SC - Seychelles 3
AR - Argentina 2
AZ - Azerbaigian 2
BG - Bulgaria 2
CL - Cile 2
EC - Ecuador 2
EG - Egitto 2
PK - Pakistan 2
PY - Paraguay 2
UZ - Uzbekistan 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AU - Australia 1
BY - Bielorussia 1
DK - Danimarca 1
GE - Georgia 1
HU - Ungheria 1
KE - Kenya 1
KH - Cambogia 1
KR - Corea 1
LB - Libano 1
LK - Sri Lanka 1
LT - Lituania 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
NZ - Nuova Zelanda 1
OM - Oman 1
RO - Romania 1
RS - Serbia 1
SA - Arabia Saudita 1
TN - Tunisia 1
Totale 10.979
Città #
Jacksonville 1.033
Dublin 686
Singapore 626
Chandler 580
Southend 557
Princeton 351
Izmir 340
Nanjing 321
Wilmington 191
Cambridge 171
Santa Clara 136
The Dalles 131
Beijing 121
Nanchang 119
Dearborn 114
Altamura 99
Ann Arbor 76
Boardman 62
Ashburn 58
Kunming 58
Woodbridge 57
Shenyang 54
Grevenbroich 52
Moscow 49
Tianjin 42
Hebei 41
Jiaxing 35
Los Angeles 27
Pune 27
Changsha 26
Norwalk 26
Hangzhou 24
Chieti 22
Lanzhou 21
Houston 20
Augusta 18
Brno 18
San Mateo 18
Toronto 18
Helsinki 15
Rome 13
Andover 12
Jinan 12
Brussels 11
Changchun 11
Munich 11
Hong Kong 9
Nuremberg 9
Orange 9
Radomsko 9
São Paulo 8
Vienna 8
Dong Ket 7
Falls Church 7
Leawood 7
Ningbo 7
Rio de Janeiro 7
Auburn Hills 6
Guangzhou 6
New York 6
Washington 6
Düsseldorf 5
Haikou 5
Milan 5
Rufina 5
Sant'onofrio 5
Seattle 5
Shanghai 5
Simi Valley 5
Belo Horizonte 4
Cedar Knolls 4
Kocaeli 4
London 4
Monmouth Junction 4
Pescara 4
Pisa 4
Zhengzhou 4
Ardabil 3
Bogotá 3
Brasília 3
Campinas 3
Caruaru 3
Caxias do Sul 3
Civitavecchia 3
Edinburgh 3
Grafing 3
Madrid 3
Mexico City 3
Mileto 3
Mumbai 3
Niterói 3
Noto 3
Taizhou 3
Venafro 3
Walnut 3
Baku 2
Bangalore 2
Bari 2
Berazategui 2
Cairo 2
Totale 6.757
Nome #
Caso clinico di endoplastite da Staphylococcus capitis. 143
La sindrome di Waterhouse-Friderichsen quale complicanza fatale nel bambino febbrile: descrizione di due casi clinici. 114
Ricerche sull'autoimmunità in alcune epatopatie. 112
HPV e displasie della cervice uterina: ricerca dell'HPV-DNA con PCR e correlazioni con l'esame citologico, colposcopico e istobioptico 110
Differential expression of interferon-induced microRNAs in patients with chronic hepatitis C virus infection treated with pegylated interferon alpha 109
Association between plasma interleukin-18 levels and liver injury in chronic hepatitis C-virus infection and non-alcoholic fatty liver disease. 108
Valutazione della sindrome da fatica cronica mediante A.B.R.: risultati preliminari 107
Cytokine patterns correlate with liver damage in patients with chronic hepatitis B and C. 103
Metabolic modifications in HIV-infected women 101
Cytomegalovirus infection in heart-transplants recipients, in a central region of Italy 101
Ricerca con PCR e genotipizzazione dell'HPVDNA in donne con dispiasia della cervice uterina e nei loro partner 98
Autoimmunità nelle epatiti croniche in terapia con IFN-alfa 96
I potenziali evocati uditivi troncoencefalici nella valutazione della Sindrome da Fatica Cronica. 96
Alterations in muscles of CFS patients at morphological. biochemical and molecular level. 94
Interleukin-4 and interferon-gamma production during HIV-1 infection and changes induced by antiretroviral therapy. 93
Specific oxidative alterations in vastus lateralis muscle of patients with the diagnosis of chronic fatigue syndrome. 93
Associations between hypertriglyceridemia and serum ghrelin, adiponectin, and IL-18 levels in HIV-infected patients. 91
Could S-100b be a marker of the neurologic involvement in HIV-affected patients? 88
Treatment with silibyn- Vitamin E- Phospholipid complex in patients with Hepatitis C infection. 88
Acute urinary retention due to HSV-1: a case report 86
Economic evaluation on HIV treatments: The I.Co.N.A. cohort study. 86
Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus 86
Ocular manifestations in chronic fatigue syndrome. 85
Efficacia clinica del trattamento intravescicale con BCG per neoplasie vescicali superficiali in rapporto alla risposta immunitaria indotta. 84
A leukemic patient with hepatosplenic abscesses due to coagulase-negative staphylococci. 84
Is moderate HIV-viremia associated with a higher risk of clinical progression in HIV-infected people treated with high active antiretroviral therapy. 84
Usefulness of Leifson staining method in diagnosis of Helicobacter pylori infection. 84
Circadian variations of prolactine (PRL), thyreotropic hormone (TSH), adrenocorticotropic hormone (ACTH) and cortisol (CS) in the chronic fatigue syndrome (CFS). 83
Multicentre study on the prevalence of symptoms and symptomatic treatment in HIV infection. 83
Quality of life, depression and cytokine patterns in patients with chronic hepatitis C treated with antiviral therapy. 83
Psychiatric diagnosis and comorbidity and chronic fatigue syndrome 82
Valutazione comparativa delle tecniche di immunodiffusione su agar e counter-elettroforesi nella ricerca dell'antigene Australia. 82
Peripheral blood mononuclear cell beta-endorphin concentration is decreased in chronic fatigue syndrome and fibromyalgia but not in depression: preliminary report 82
Inguinal lymphadenopathy due to Bartonella henselae 81
Cystatin C, adipokines and cardiovascular risk in HIV infected patients. 81
Acquired immunodeficiency without HIV infection: epidemiology and clinical autcome in Italy. 80
Vertical transmission of hepatitis C virus: an epidemiological study on 2,980 pregnant women in Italy. 80
Neurite acistica bilaterale HIV-correlata: descrizione di un caso ad evoluzione favorevole in seguito a terapia antiretrovirale. 79
Proteinuria in an African HIV-infected patient: effects of telmisartan. 79
Use of epoetin beta during combination therapy of infection with hepatitis c virus with ribavirin improves a sustained viral response. 79
Hepatitis C virus infection and myositis: a virus localization study. 78
Interruption of highly active antiretroviral therpy in HIV clinical practice. 77
Effetti del trattamento con vitamina e sulla sintomatologia muscoloscheletrica soggettiva ed oggettiva della sindrome da fatica cronica 77
An unusual complication of brucellosis: hepatic abscess. 76
Evolution of HVR-1 quasispecies after 1-year treatment in HIV/HCV-coinfected patients according to the pattern of response to highly active antiretroviral therapy. 76
Chronic fatigue syndrome: circadian rhythm and hypothalamic-pituitary-adrenal (HPA) axis impairment. 75
The association of chronic hepatitis B and myopathy 75
Involvement of novel human immunodeficiency virus type 1 reverse transcriptase mutations in the regulation of resistance to nucleoside inhibitors. 75
Improved metabolic profile after switch to darunavir/ritonavir in HIV positive patients previously on protease inhibitor therapy. 75
Patient-reported and Physician-estimated Adherence to HAART. 75
High dose of erythropoietin in management of interferon/ribavirin induced anemia 74
Methicillin-resistant staphylococcus epidermidis (MRSE) endocarditis treated with linezolid 74
Viral interference between hepatitis B, C and D viruses in dual and triple infections in HIV-positive patients. 74
Insights the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naive patients 74
Sensory characterization of somatic parietal tissues in humans with chronic fatigue syndrome 73
Increased production of oncostatin-M by lymphomononuclear cells from HIV-1-infected patients with neuroAIDS. 73
Short communication: Proangiogenic hematopoietic cells in acute HIV infection 72
MR imaging in the clinical diagnosis of chronic fatigue syndrome (CFS). 71
Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: Data from the ICONA cohort 71
Mortality from HIV and TB coinfections in higher in Eastern Europe than in Western Europe and Argentina. 70
Psychophysical distress and alexithymic traits in chronic fatigue syndrome with and without comorbid depression 70
Nuovi aspetti della terapia antibiotica associata (rassegna critica e contributo personale). 70
Ulteriori osservazioni sul sistema HBeAg-HBeAb in corso di epatite ed in portatori di HBsAg. 70
Ricerca dell'anticorpo contro il virus A (=HAAb) per l'epidemiologia e la diagnosi dell'epatite A. 70
Clinical and Pathogenetical Characterization of 238 Patients of a Chronic Fatigue Syndrome Italian Center 69
Study of immune alterations in patients with Chronic Fatigue Syndrome to reach a better nosografic and pathogenetic characterization of subgroups with different etiologies. 69
Attualità sulle infezioni batteriche del SNC. 69
Metabolic syndrome and cardiovascular risk in HIV-infected patients with lipodystrophy. 69
Predictability of sustained virological response to pegylate interferon alpha-2b plus ribavirin therapy by week-8 viral response in HIV-positive patients with chronic hepatitis C infection. 69
Antiretroviral therapy in HIV-infected individuals in clinical practice: are the criteria for initiating and choosing the type of drug regimen based only on immunologic and virologic values? 69
Chronic fatigue syndrome following a toxic exposure. 68
The impact of rufloxacin given as prophylaxis to patients with cancer on their oral and faecal microflora. 68
Antibodies to hepatitis A virus in Italian patients with chronic liver disease 67
Granulomatous cheilitis in an HIV positive patient on HAART Therapy. 67
Comparative analysis of two systems for HCV genotyping. 66
Le associazioni di antibiotici: aspetti clinici. 66
Adherence to highly active antiretroviral therapy is better in patients receiving non-nucleoside reverse transcriptase inhibitor-containing regimens than in those receiving protease inhibitor-containing. 66
b-endorphin concentrations are decreased in peripheral blood mononuclear cells of chronic fatigue syndrome patients: comparison with depression. 66
Use of hematopoietic growth factor in the management of hematological side effects associated to antiviral treatment for HCV hepatitis. 65
Ricerca degli anticorpi fissanti il complemento contro il virus dell'herpes simplex (ed altri virus neurotropi) in pazienti con sclerosi multipla. 65
Research on a new hepatitis B antigen-antibody system: e- anti-e. 65
Genetic polymorphisms differently influencing the emergence of atrophy and far accumulation in HIV-related lipodystrophy. 65
Response to HAART and GB virus type C coinfection in a cohort of antiretroviral-naive HIV-infected individuals. 64
L'immunità cellulare nelle epatopatie: stimolazione in vitro dei linfociti con antigeni epatici. 63
Risk of developing specific AIDS-defining illness in patients coinfected with HIV and hepatitis C virus with or without cirrhosis. 62
Inflammatory cytokines and S-100b protein in patients with hepatitis C infection and cryoglobulinemias 62
Ricerche su donatori di sangue Au-positivi: stimolazione in vitro dei linfociti con PHA. 62
Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy 62
Determinazione dell'antigene Australia con il metodo radioimmunologico in corso di epatite virale. 61
Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes 60
Submaximal aerobic exercise with mechanical vibrations improves the functional status of patients with Chronic Fatigue Sindrome. 59
Chromatographic and electrophoretic studies of immune complexes in non-A, non-B hepatitis. 59
Relationship between musculoskeletal symptoms and blood markers of oxidative stress in patients with chronic fatigue syndrome 59
An Italian study on health-related quality of life and fatigue in patients with chronic fatigue syndrome and patients with chronic HCV virus infection: similarities and differences 59
Occurence of bacteriemia in hematological patients. 58
Behavioral correlates of adherence to antiretroviral therapy. 57
Cardiovascular disease risk factors in HIV patients-association with antiretroviral therapy. Results from the DAD study. 57
Prognostic factors of early fatal outcome and long-term survival in patients with pneumocistis carinii pneumonia and acquired immunodeficiency syndrome. 55
Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in cohort of antiretroviral-naive HIV-infected individuals. 55
HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies. 55
Totale 7.720
Categoria #
all - tutte 46.610
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.610


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020235 0 0 0 0 0 0 0 0 0 0 223 12
2020/2021991 185 9 185 4 88 197 8 6 83 179 12 35
2021/2022597 7 3 5 103 47 12 11 68 52 13 85 191
2022/20231.921 206 271 112 187 178 404 136 112 226 18 27 44
2023/2024708 58 27 34 18 33 205 238 19 0 6 5 65
2024/20251.921 216 579 468 33 21 48 7 145 228 138 38 0
Totale 11.205